Patent · US Active

PIIINP neo-epitope assay

US9726674B2 · kind B2 · utility

0Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 15, 2014
Grant dateAug 8, 2017
Priority date
Expiry dateApr 15, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7052
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided is a monoclonal antibody specifically reactive with a C-terminal neo-epitope of PIIINP comprised in a C-terminal amino acid sequence CPTGXQNYSP-COOH (SEQ ID NO: 4) in which X is Gly or Pro, and where the monoclonal antibody does not recognize or bind an elongated version of the C-terminal amino acid sequence CPTGXQNYSPQZ-COOH (SEQ ID NO: 5), in which Z is absent or is one or more amino acids of the sequence of collagen type III. Also provided is a method of immunoassay for detecting in a biological sample the C-terminal neo-epitope of PIIINP generated by N-protease cleavage of intact type III procollagen, by contacting the sample with the monoclonal antibody, and determining the amount of binding of the antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.